AN Venture Partners Announces Final Close of $200M Fund I, MUFG & SMBC Participate
AN Venture Partners (ANV), a global biotech venture capital firm, announced the final close of its first fund, AN Venture Partners I, achieving its target of USD 200m (JPY 29bn), one of the largest Japan-focused biotech venture capital funds to date, and also one of the largest first-time biotech venture capital funds raised in the past year.
More than 20 Limited Partners (LPs) have invested in the fund, led by Japan Investment Corporation, Shionogi & Co., Otsuka Pharmaceutical, MUFG Bank, and Sumitomo Mitsui Banking Corporation.
